Feasibility of Emotion Regulation Group Therapy for Adolescent Self-Harm (NCT06297824) | Clinical Trial Compass
CompletedNot Applicable
Feasibility of Emotion Regulation Group Therapy for Adolescent Self-Harm
Sweden21 participantsStarted 2023-10-10
Plain-language summary
Deliberate self-harm (DSH) is a prevalent behaviour among adolescents but there is no current recommendation for an efficacious treatment. Emotion regulation group therapy (ERGT) is a brief treatment for DSH with a well-documented utility and feasibility in the adult population, and an adapted version for adolescents may provide equal benefits for adolescents, provided adjustments to prevent or decrease social contagion are present.
A quantitative feasibility open trial (N=20) followed up by a qualitative interview study will examine the feasibility, acceptability and preliminary effect of ERGT for adolescents.
Who can participate
Age range13 Years – 17 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. 13-17 years of age;
✓. having engaged in deliberate self-harm (DSH)-behaviours ≥ 5 times the last year;
✓. having engaged in ≥1 DSH episode during the past month;
✓. having ongoing psychiatric treatment in the community;
✓. having at least one caregiver or other significant adult, committed to participate in the parent program; and
✓. stability of psychotropic medications
Exclusion criteria
✕. a diagnosis of psychotic, bipolar I disorder or severe social anxiety disorder (SAD);
✕. ongoing substance dependence;
✕. the presence of co-occurring psychiatric disorders that require immediate treatment;
✕. having an autism spectrum disorder together with borderline intellectual disability or having an intellectual disability;
What they're measuring
1
Feasibility measure, recruitment rate
Timeframe: through study completion, an average of 1 year
2
Feasibility measures, proportion included
Timeframe: through study completion, an average of 1 year
3
Feasibility measures, compliance
Timeframe: Pre-treatment to post-treatment (End of treatment, EOT) (12 weeks)
4
Feasibility measures, attrition
Timeframe: Pre-treatment to post-treatment EOT (12 weeks)
5
Feasibility measures, client satisfaction
Timeframe: at post-treatment EOT (12 weeks)
6
Feasibility measures, negative effects of treatment